Supply of the drug named "PHESGO 600 MG/600 MG SC C/1".

This tender concerns the procurement and supply of a specific pharmaceutical product, identified as "PHESGO 600 MG/600 MG SC C/1". The primary objective of this contract is to ensure the availability of this particular medication. While the description is concise, it clearly defines the scope of work as the provision of this named drug. Further details regarding the quantity, delivery timelines, specific storage and handling requirements, and the intended recipient or healthcare facility are not explicitly stated in the provided description but would be crucial components of the full tender documentation. This procurement likely falls within the healthcare or pharmaceutical sector, aiming to meet medical needs within a specific region or institution. Bidders are expected to demonstrate their capability to supply this drug according to the specifications outlined in the complete tender documents, which would include information on quality standards, regulatory compliance, and logistical arrangements. The successful bidder will be responsible for the reliable and timely delivery of "PHESGO 600 MG/600 MG SC C/1" to the designated location, ensuring it meets all necessary pharmaceutical standards and requirements.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals and General Supplies. Located in Spain, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.